150 related articles for article (PubMed ID: 24664730)
1. Dominant Stargardt Macular Dystrophy (STGD3) and ELOVL4.
Logan S; Anderson RE
Adv Exp Med Biol; 2014; 801():447-53. PubMed ID: 24664730
[TBL] [Abstract][Full Text] [Related]
2. Deciphering mutant ELOVL4 activity in autosomal-dominant Stargardt macular dystrophy.
Logan S; Agbaga MP; Chan MD; Kabir N; Mandal NA; Brush RS; Anderson RE
Proc Natl Acad Sci U S A; 2013 Apr; 110(14):5446-51. PubMed ID: 23509295
[TBL] [Abstract][Full Text] [Related]
3. Mutant ELOVL4 that causes autosomal dominant stargardt-3 macular dystrophy is misrouted to rod outer segment disks.
Agbaga MP; Tam BM; Wong JS; Yang LL; Anderson RE; Moritz OL
Invest Ophthalmol Vis Sci; 2014 May; 55(6):3669-80. PubMed ID: 24833735
[TBL] [Abstract][Full Text] [Related]
4. Role of ELOVL4 and very long-chain polyunsaturated fatty acids in mouse models of Stargardt type 3 retinal degeneration.
Barabas P; Liu A; Xing W; Chen CK; Tong Z; Watt CB; Jones BW; Bernstein PS; Križaj D
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5181-6. PubMed ID: 23479632
[TBL] [Abstract][Full Text] [Related]
5. Current Progress in Deciphering Importance of VLC-PUFA in the Retina.
Bennett LD; Anderson RE
Adv Exp Med Biol; 2016; 854():145-51. PubMed ID: 26427405
[TBL] [Abstract][Full Text] [Related]
6. Biosynthesis of very long-chain polyunsaturated fatty acids in hepatocytes expressing ELOVL4.
Agbaga MP; Logan S; Brush RS; Anderson RE
Adv Exp Med Biol; 2014; 801():631-6. PubMed ID: 24664752
[TBL] [Abstract][Full Text] [Related]
7. Epidermal expression of an Elovl4 transgene rescues neonatal lethality of homozygous Stargardt disease-3 mice.
McMahon A; Butovich IA; Kedzierski W
J Lipid Res; 2011 Jun; 52(6):1128-1138. PubMed ID: 21429867
[TBL] [Abstract][Full Text] [Related]
8. Dominant negative mechanism underlies autosomal dominant Stargardt-like macular dystrophy linked to mutations in ELOVL4.
Grayson C; Molday RS
J Biol Chem; 2005 Sep; 280(37):32521-30. PubMed ID: 16036915
[TBL] [Abstract][Full Text] [Related]
9. Atrophic macular degeneration mutations in ELOVL4 result in the intracellular misrouting of the protein.
Ambasudhan R; Wang X; Jablonski MM; Thompson DA; Lagali PS; Wong PW; Sieving PA; Ayyagari R
Genomics; 2004 Apr; 83(4):615-25. PubMed ID: 15028284
[TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Stargardt 3 Dominant Macular Degeneration.
Barabas P; Gorusupudi A; Bernstein PS; Krizaj D
Adv Exp Med Biol; 2016; 854():137-43. PubMed ID: 26427404
[TBL] [Abstract][Full Text] [Related]
11. Genetics and molecular pathology of Stargardt-like macular degeneration.
Vasireddy V; Wong P; Ayyagari R
Prog Retin Eye Res; 2010 May; 29(3):191-207. PubMed ID: 20096366
[TBL] [Abstract][Full Text] [Related]
12. A novel mutation in the ELOVL4 gene causes autosomal dominant Stargardt-like macular dystrophy.
Maugeri A; Meire F; Hoyng CB; Vink C; Van Regemorter N; Karan G; Yang Z; Cremers FP; Zhang K
Invest Ophthalmol Vis Sci; 2004 Dec; 45(12):4263-7. PubMed ID: 15557430
[TBL] [Abstract][Full Text] [Related]
13. Endoplasmic reticulum microenvironment and conserved histidines govern ELOVL4 fatty acid elongase activity.
Logan S; Agbaga MP; Chan MD; Brush RS; Anderson RE
J Lipid Res; 2014 Apr; 55(4):698-708. PubMed ID: 24569140
[TBL] [Abstract][Full Text] [Related]
14. Stargardt Phenotype Associated With Two ELOVL4 Promoter Variants and ELOVL4 Downregulation: New Possible Perspective to Etiopathogenesis?
Donato L; Scimone C; Rinaldi C; Aragona P; Briuglia S; D'Ascola A; D'Angelo R; Sidoti A
Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):843-857. PubMed ID: 29417145
[TBL] [Abstract][Full Text] [Related]
15. Role of Stargardt-3 macular dystrophy protein (ELOVL4) in the biosynthesis of very long chain fatty acids.
Agbaga MP; Brush RS; Mandal MN; Henry K; Elliott MH; Anderson RE
Proc Natl Acad Sci U S A; 2008 Sep; 105(35):12843-8. PubMed ID: 18728184
[TBL] [Abstract][Full Text] [Related]
16. A novel ELOVL4 variant, L168S, causes early childhood-onset Spinocerebellar ataxia-34 and retinal dysfunction: a case report.
Gyening YK; Boris K; Cyril M; Brush RS; Nassogne MC; Agbaga MP
Acta Neuropathol Commun; 2023 Aug; 11(1):131. PubMed ID: 37568198
[TBL] [Abstract][Full Text] [Related]
17. Association of adipose and red blood cell lipids with severity of dominant Stargardt macular dystrophy (STGD3) secondary to an ELOVL4 mutation.
Hubbard AF; Askew EW; Singh N; Leppert M; Bernstein PS
Arch Ophthalmol; 2006 Feb; 124(2):257-63. PubMed ID: 16476896
[TBL] [Abstract][Full Text] [Related]
18. Corneal involvement in a case of autosomal dominant Stargardt-like macular dystrophy (STGD3) with
Zhai Y; Benson MD; MacDonald IM
Ophthalmic Genet; 2022 Feb; 43(1):134-136. PubMed ID: 34596007
[No Abstract] [Full Text] [Related]
19. Effect of reduced retinal VLC-PUFA on rod and cone photoreceptors.
Bennett LD; Brush RS; Chan M; Lydic TA; Reese K; Reid GE; Busik JV; Elliott MH; Anderson RE
Invest Ophthalmol Vis Sci; 2014 Apr; 55(5):3150-7. PubMed ID: 24722693
[TBL] [Abstract][Full Text] [Related]
20. A 5-bp deletion in ELOVL4 is associated with two related forms of autosomal dominant macular dystrophy.
Zhang K; Kniazeva M; Han M; Li W; Yu Z; Yang Z; Li Y; Metzker ML; Allikmets R; Zack DJ; Kakuk LE; Lagali PS; Wong PW; MacDonald IM; Sieving PA; Figueroa DJ; Austin CP; Gould RJ; Ayyagari R; Petrukhin K
Nat Genet; 2001 Jan; 27(1):89-93. PubMed ID: 11138005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
